These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 25224616)

  • 41. Preferences for oral PrEP dosing among adolescent boys and young men in three sub-Saharan African countries.
    Kakande A; Ssemata AS; Muhumuza R; Atujuna M; Abaasa A; Ndekezi D; Tshabalala G; Nematadzira T; Hornschuh S; Nomvuyo M; Ahmed N; Maluadzi M; Anne Weiss H; Webb E; Stranix-Chibanda L; Janine Dietrich J; Seeley J; Fox J
    PLoS One; 2023; 18(10):e0285132. PubMed ID: 37812644
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Perspectives of South African youth in the development of an implant for HIV prevention.
    Krogstad EA; Atujuna M; Montgomery ET; Minnis A; Ndwayana S; Malapane T; Shapley-Quinn MK; Manenzhe K; Bekker LG; van der Straten A
    J Int AIDS Soc; 2018 Aug; 21(8):e25170. PubMed ID: 30152004
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Willingness to use HIV prevention methods among vaccine efficacy trial participants in Soweto, South Africa: discretion is important.
    Laher F; Salami T; Hornschuh S; Makhale LM; Khunwane M; Andrasik MP; Gray GE; Van Tieu H; Dietrich JJ
    BMC Public Health; 2020 Nov; 20(1):1669. PubMed ID: 33160341
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Barriers and facilitators to pre-exposure prophylaxis (PrEP) eligibility screening and ongoing HIV testing among target populations in Bondo and Rarieda, Kenya: results of a consultation with community stakeholders.
    Mack N; Odhiambo J; Wong CM; Agot K
    BMC Health Serv Res; 2014 May; 14():231. PubMed ID: 24886646
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Preferences for Long-Acting PrEP Products Among Women and Girls: A Quantitative Survey and Discrete Choice Experiment in Eswatini, Kenya, and South Africa.
    Little KM; Hanif H; Anderson SM; Clark MR; Gustafson K; Doncel GF
    AIDS Behav; 2024 Mar; 28(3):936-950. PubMed ID: 37971614
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Service delivery models that promote linkages to PrEP for adolescent girls and young women and men in sub-Saharan Africa: a scoping review.
    Ramraj T; Chirinda W; Jonas K; Govindasamy D; Jama N; McClinton Appollis T; Zani B; Mukumbang FC; Basera W; Hlongwa M; Turawa EB; Mathews C; Nicol E
    BMJ Open; 2023 Mar; 13(3):e061503. PubMed ID: 36972966
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Delivering safer conception services to HIV serodiscordant couples in Kenya: perspectives from healthcare providers and HIV serodiscordant couples.
    Ngure K; Kimemia G; Dew K; Njuguna N; Mugo N; Celum C; Baeten JM; Heffron R
    J Int AIDS Soc; 2017 Mar; 20(Suppl 1):21309. PubMed ID: 28361508
    [TBL] [Abstract][Full Text] [Related]  

  • 48. "The Time Has Arrived": Perceptions of Behavioral Adjustments in the Context of Pre-Exposure Prophylaxis Availability Among Adolescents in South Africa.
    Giovenco D; Kuo C; Underhill K; Hoare J; Operario D
    AIDS Educ Prev; 2018 Dec; 30(6):463-473. PubMed ID: 30966763
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Impact along the HIV pre-exposure prophylaxis "cascade of prevention" in western Kenya: a mathematical modelling study.
    Bershteyn A; Sharma M; Akullian AN; Peebles K; Sarkar S; Braithwaite RS; Mudimu E
    J Int AIDS Soc; 2020 Jun; 23 Suppl 3(Suppl 3):e25527. PubMed ID: 32602669
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Interest in Long-Acting Injectable Pre-exposure Prophylaxis (LAI PrEP) Among Women in the Women's Interagency HIV Study (WIHS): A Qualitative Study Across Six Cities in the United States.
    Philbin MM; Parish C; Kinnard EN; Reed SE; Kerrigan D; Alcaide ML; Cohen MH; Sosanya O; Sheth AN; Adimora AA; Cocohoba J; Goparaju L; Golub ET; Fischl M; Metsch LR
    AIDS Behav; 2021 Mar; 25(3):667-678. PubMed ID: 32910351
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Health care providers' attitudes toward and experiences delivering oral PrEP to adolescent girls and young women in Kenya, South Africa, and Zimbabwe.
    Lanham M; Ridgeway K; Mireku M; Nhamo D; Pillay D; Murire M; Stankevitz K; Kyongo J; Mullick S;
    BMC Health Serv Res; 2021 Oct; 21(1):1112. PubMed ID: 34663320
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sexual health needs of female sex workers in Côte d'Ivoire: a mixed-methods study to prepare the future implementation of pre-exposure prophylaxis (PrEP) for HIV prevention.
    Becquet V; Nouaman M; Plazy M; Masumbuko JM; Anoma C; Kouame S; Danel C; Eholie SP; Larmarange J;
    BMJ Open; 2020 Jan; 10(1):e028508. PubMed ID: 31919122
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Current status of the female condom in Africa].
    Deniaud F
    Sante; 1997; 7(6):405-15. PubMed ID: 9503499
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Implants for HIV prevention in young women: Provider perceptions and lessons learned from contraceptive implant provision.
    Humphries H; Upfold M; Mahlase G; Mdladla M; Gengiah TN; Abdool Karim Q
    PLoS One; 2022; 17(1):e0262043. PubMed ID: 35025908
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Attitudes and acceptance of oral and parenteral HIV preexposure prophylaxis among potential user groups: a multinational study.
    Eisingerich AB; Wheelock A; Gomez GB; Garnett GP; Dybul MR; Piot PK
    PLoS One; 2012; 7(1):e28238. PubMed ID: 22247757
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Attitudes of serodiscordant couples towards antiretroviral-based HIV prevention strategies in Kenya: a qualitative study.
    Fowler N; Arkell P; Abouyannis M; James C; Roberts L
    J Int AIDS Soc; 2014; 17(4 Suppl 3):19563. PubMed ID: 25394070
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Factors influencing uptake, continuation, and discontinuation of oral PrEP among clients at sex worker and MSM facilities in South Africa.
    Pillay D; Stankevitz K; Lanham M; Ridgeway K; Murire M; Briedenhann E; Jenkins S; Subedar H; Hoke T; Mullick S
    PLoS One; 2020; 15(4):e0228620. PubMed ID: 32352969
    [TBL] [Abstract][Full Text] [Related]  

  • 58. HIV-1 self-testing to improve the efficiency of pre-exposure prophylaxis delivery: a randomized trial in Kenya.
    Ortblad KF; Kearney JE; Mugwanya K; Irungu EM; Haberer JE; Barnabas RV; Donnell D; Mugo NR; Baeten JM; Ngure K
    Trials; 2019 Jul; 20(1):396. PubMed ID: 31272495
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A qualitative study to identify critical attributes and attribute-levels for a discrete choice experiment on oral pre-exposure prophylaxis (PrEP) delivery among young people in Cape Town and Johannesburg, South Africa.
    Dietrich JJ; Atujuna M; Tshabalala G; Hornschuh S; Mulaudzi M; Koh M; Ahmed N; Muhumuza R; Ssemata AS; Otwombe K; Bekker LG; Seeley J; Martinson NA; Terris-Prestholt F; Fox J
    BMC Health Serv Res; 2021 Jan; 21(1):17. PubMed ID: 33407395
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Key barriers and enablers associated with uptake and continuation of oral pre-exposure prophylaxis (PrEP) in the public sector in Zimbabwe: Qualitative perspectives of general population clients at high risk for HIV.
    Gombe MM; Cakouros BE; Ncube G; Zwangobani N; Mareke P; Mkwamba A; Prescott MR; Bhatasara T; Murwira M; Mangwiro AZ; Prust ML
    PLoS One; 2020; 15(1):e0227632. PubMed ID: 31931514
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.